Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPKAPK5 | Q8IW41 | 1/20 | 0.43 |
| ▸ | TTK | P33981 | 9/20 | 0.42 |
| ▸ | SYK | P43405 | 4/20 | 0.40 |
| ▸ | PTK6 | Q13882 | 3/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.37 |
| ▸ | CDK2 | P24941 | 1/20 | 0.37 |
| ▸ | AURKA | O14965 | 1/20 | 0.37 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22122913 | 0.96 | MAPKAPK5 (0.41) | MAPKAPK5TTKSYKPTK6AURKB | |
| SCHEMBL30171674 | 0.96 | MAPKAPK5 (0.41) | MAPKAPK5TTKSYKPTK6AURKB | |
| SCHEMBL22124330 | 0.93 | MAPKAPK5 (0.42) | MAPKAPK5TTKSYKPTK6AURKB | |
| SCHEMBL22154245 | 0.92 | MAPKAPK5 (0.42) | MAPKAPK5TTKSYKPTK6AURKB | |
| SCHEMBL22123361 | 0.91 | MAPKAPK5 (0.44) | MAPKAPK5TTKSYKPTK6AURKB | |
| SCHEMBL24112349 | 0.91 | MAPKAPK5 (0.41) | MAPKAPK5TTKSYKPTK6AURKB | |
| SCHEMBL22124747 | 0.91 | MAPKAPK5 (0.41) | MAPKAPK5TTKSYKPTK6AURKB | |
| SCHEMBL22142784 | 0.91 | MAPKAPK5 (0.41) | MAPKAPK5TTKSYKPTK6AURKB | |
| SCHEMBL22123086 | 0.90 | PTK6 (0.48) | MAPKAPK5TTKPTK6AURKB | |
| SCHEMBL22139064 | 0.90 | MAPKAPK5 (0.46) | MAPKAPK5TTKSYKPTK6AURKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3898631-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | F. Hoffmann-La Roche AG (CH) | 2021-10-27 | — | — | EP | disclosed |
| EP-3897840-A1 | IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS | F. Hoffmann-La Roche AG (CH) | 2021-10-27 | — | — | EP | disclosed |
| EP-3898629-A1 | IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | F. Hoffmann-La Roche AG (CH) | 2021-10-27 | — | — | EP | disclosed |
| EP-3898630-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2021-10-27 | — | — | EP | disclosed |
| EP-3897839-A1 | IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS | F. Hoffmann-La Roche AG (CH) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020126956-A1 | IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-25 | — | — | WO | disclosed |
| WO-2020126954-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-25 | — | — | WO | disclosed |
| WO-2020126953-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-25 | — | — | WO | disclosed |
| WO-2020127075-A1 | IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-25 | — | — | WO | disclosed |
| WO-2020126952-A1 | IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-25 | — | — | WO | disclosed |